Mesenchymal Cell Therapy in Osteogenesis Imperfecta (OI)
NCT05559801
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Osteogenesis Imperfecta
Osteogenesis Imperfecta Type III
Interventions
DRUG:
Bone marrow-derived mesenchymal stromal cells (MSCs)
Sponsor
Emory University